Related references
Note: Only part of the references are listed.The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents
Tatjana Haitina et al.
BMC GENOMICS (2009)
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Mauro Perretti et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation
Takao Shimizu
Annual Review of Pharmacology and Toxicology (2008)
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
Aksam J. Merched et al.
FASEB JOURNAL (2008)
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
Jenna L. Cash et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2
Toshiaki Okuno et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
Kie Kasuga et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Structural basis for the activation of PPARγ by oxidized fatty acids
Toshimasa Itoh et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D. Barish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Immunomodulation by omega-3 fatty acids
Philip C. Calder
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Resolvin D1 and its aspirin-triggered 17R epimer -: Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation
Yee-Ping Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
β galactosidase complementation:: A cell-based luminescent assay platform for drug discovery
Keith R. Olson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
Charles N. Serhan
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Resolvin D series and Protectin D1 mitigate acute kidney injury
Jeremy S. Duffield et al.
JOURNAL OF IMMUNOLOGY (2006)
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Roland W. Burli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo
Nan Chiang et al.
PHARMACOLOGICAL REVIEWS (2006)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Taking insult from injury: Lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells
P Maderna et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation
SJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential inside-out activation of β2-integrins by leukotriene B4 and fMLP in human neutrophils
V Patcha et al.
EXPERIMENTAL CELL RESEARCH (2004)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics
M Perretti et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation
N Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
